Several other research analysts also recently issued reports on AFX. Berenberg Bank set a €48.00 ($59.26) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Tuesday, October 17th. DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research note on Thursday, October 19th. set a €52.00 ($64.20) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Friday, November 10th. Deutsche Bank set a €40.00 ($49.38) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, December 1st. Finally, Commerzbank set a €42.00 ($51.85) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, December 8th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. The company has an average rating of Hold and an average target price of €52.88 ($65.28).
Carl Zeiss Meditec (AFX) opened at €49.10 ($60.62) on Wednesday. The stock has a market cap of $4,430.00 and a P/E ratio of 32.52. Carl Zeiss Meditec has a 52 week low of €37.35 ($46.11) and a 52 week high of €55.25 ($68.21).
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.